Connect with us

International

S&P 500 (INDEXSP: .INX) in the red for a third straight day

S&P 500 (INDEXSP: .INX) in the red for a third straight day

Published

on

euro stoxx 50 index Zoetis Beckton Dickinson

September 18, 2020 Update: The S&P 500 (INDEXSP: .INX) declined for a third consecutive day amid fears about the economic recovery in the U.S. and a new global surge in coronavirus infections. Today is also a “quadruple witching” day, which doesn’t help matters any. There is one such day every quarter when volatility is increased due to the expiration of futures and options on indexes and equities.

The S&P has been trading lower since Wednesday when the Federal Reserve signaled it would hold interest rates near zero for years as the economy continues to reel from the pandemic. Stocks were also pressured as the prospects of further stimulus from Congress grow even dimmer.

S&P 500 (INDEXSP: .INX) continues to hover close to record

August 17, 2020 Update: The S&P 500 (INDEXSP: .INX) is hovering close to a record high today. Investors remain unconcerned about the lack of a stimulus deal among U.S. lawmakers, not to mention renewed tensions between the U.S. and China and the COVID-19 pandemic.

If the S&P hits a record high this week, it would be the first time that happened since February. What’s even more remarkable than that is the fact that the index would even hit a record at all with the pandemic, which is causing the economy to struggle.

CNN notes that if the S&P 500 (INDEXSP: .INX) does hit a new record high soon, it would mean that it took only about five months for it to climb from its recent low during the March selloff to a new record. The index has been hovering close to a new record high for some time, but it has repeatedly failed to break through.

A new bull market for the INDEXSP: .INX?

Some might say that a new record would mark the end of the bear market caused by the pandemic, making it the shortest ever at only 1.1 months. However, other definitions suggest another month would have to go by before there would be a confirmation that a new bull market is underway.

The general definition of a bull market is a 20% rally off the previous low without undercutting it within six months. The S&P 500 is on track for that in September unless things change.

Bubble territory, earnings and how to buy

The S&P 500 (INDEXSP: .INX) is now back in bull territory. The index is currently at 3,270.92 as of late trading on July 22nd 2020. The return is only 1.37% YTD due to a big drop earlier in the year. Of late, markets including the S&P500 have been rallying with the index up an impressive +16.99% in the past three months including a 5% return in the monthly of July.

Prior to mid February the index continued to hit record highs in 2020, including new highs on Feb. 11. Both the S&P and the Nasdaq touched new records as Wall Street expressed optimism in the stock market due to a slowdown in new cases of the coronavirus in China. The Dow Jones Industrial Average also soared to a new record intraday high. However, all that ended as coronavirus started spreading primarily in Italy and now the US. INX and other major indices are down on fears that most of the economy is likely to shut down.

What is the S&P 500 (INDEXSP: .INX)?

The S&P 500 is a widely used measuring stick for U.S. stocks because it tracks the stocks of 500 of the biggest companies in the nation. S&P stands for Standard and Poor, the names of the two companies that created the index originally. Henry Poor was an analyst who put together a book every year listing public railroad companies. Poor’s book was merged with the publication of the Standard Statistics Bureau in 1941.

A committee selects the companies that will be included in the S&P, but all companies must fit certain criteria before they will even be considered. The eight criteria are market capitalization, sector, liquidity, public float, domicile, financial liability, stock exchange, and length of time they have been public.

How to get included in the INX index

All companies included in the index must have a market capitalization of at least $5.3 billion. A minimum of 250,000 shares must change hands in each of the six months before the data of evaluation for inclusion in the index. The companies are also selected across all sectors to represent the economy of the U.S.

The companies must be listed on either the New York Stock Exchange or the Nasdaq, and they must be headquartered in the U.S. They must have been public for at least six months and have posted at least four consecutive quarters of positive as-reported earnings. For this reason, even though Tesla has achieved a massive market cap of $138.84 billion, it isn’t ready to be included in the S&P because it hasn’t yet posted four consecutive quarters of positive as-reported earnings.

How to buy the S&P

The easiest way to buy the S&P 500 is to invest in a passive fund that tracks the index. Some common exchange-traded funds that track the index include the Vanguard S&P 500 ETF, the SPDR S&P 500 ETF, and the iShares Core S&P 500 ETF.

It’s also possible to purchase individual stocks that are found in the S&P 500 (INDEXSP: .INX). In some ways, that may be the wiser move, although it is more complicated for individual investors.

CNN argues that the S&P 500 has basically become the S&P 5. The index’s entire market value is $26.7 trillion, and the top five stocks make up $4.85 trillion of it. The top five stocks are all tech names: Apple, Microsoft, Amazon, Alphabet and Facebook.

The last time the weighting of the index was so heavily skewed toward one sector was in 2000 right before the bursting of the dotcom bubble. Currently, Apple and Microsoft’s weightings in the index are higher than those of some industries.

Another way to buy the S&P is to buy futures contracts in the derivatives market via the Chicago Mercantile Exchange. The futures contracts track the index and trade on the exchange or CME’s Globex platform.

Is the S&P 500 (INDEXSP: .INX) overvalued or in a bubble yet?

So does this mean the S&P is overvalued or in a bubble? It depends on who you ask, but JPMorgan analysts said the index isn’t in a bubble until it reaches 3,700, Bloomberg reported in January 2020. At less than 3,400, the index is still well below that level. The firm said the S&P would have to hit 3,700 in the second half of this year to be in a bubble.

JPMorgan strategists explained that bubbles often start with two or three years of positive rolling 12-month performance. An accelerated rally follows those two or three years. This is what happened to the Dow Jones in the late 1920s, the Nasdaq 100 in the late 1990s and gold in the late 1970s. All of these situations are widely referred to as bubbles.

If the S&P 500 (INDEXSP: .INX) reaches or exceeds 3,700 in the second half of this year, it would line up with the 12-month growth rate pattern JPMorgan identified in previous bubbles. They did say the index’s performance between 2017 and 2019 does roughly line up with the performance leading into previous market bubbles. Thus, all that’s needed is one year of an accelerated rally.

Where will the S&P go this year?

Looking at the S&P more realistically, analysts are looking for the index to reach levels of 3,400 to 3,500. Of the strategists tracked by Bloomberg, 3,500 was the highest target offered for the end of this year.

In a note on Feb. 10, 2020, Canaccord Genuity analysts Tony Dwyer and Michael Welch said they are looking for a target of 3,440 at the end of this year. They downgraded their market view to Neutral recently because the index is relatively close to their target already.

INX valuation levels

They based their target on their projected earnings for the index year. They’re looking for $172 in earnings per share for the S&P in 2020. They are also assuming the operating earnings per share P/E multiple for the trailing 12 months remains around 20.

To come to a higher target for the S&P, they would have to see higher earnings per share numbers for the index this year. They add that it’s unlikely that earnings will be higher than that until more clarity is seen on the impact of the coronavirus on the global economy. On the other hand, they also say investors shouldn’t be too cautious.

“We would be careful to not get overly cautious because the monetary and fiscal backdrop should remain positive, and the U.S. economy driven by low inflation, full employment, high confidence, and a demographic tailwind to support further long-term upside,” they explained.

With their earnings estimate at $172 for 2020, Canaccord Genuity is below consensus. Consensus stands closer to $176 per share.

S&P outlook: index could rise in the double digits in 2020

On Feb. 4, 2020, Fundstrat co-founder Tom Lee told Yahoo Finance that the S&P 500 index (INDEXSP: .INX) could deliver another year of double-digit returns this year. He expects the industrial cycle to return to growth, based on a sharp increase in the latest reading on the manufacturing purchasing mangers’ index.

The ISM manufacturing PMI climbed to 50.9 last month, clocking the highest level in six months. The S&P 500 index also rebounded on Feb. 4 and 5 as fears about the coronavirus subsided. Reports of a possible treatment for it boosted the stock market on Wednesday.

The Dow Jones Industrial Average also climbed on Feb. 5, rising an impressive 1.42% by the afternoon amid signs that the spread of the coronavirus was slowing. Analysts say the Dow Jones climbed more than 200 points as Wall Street expressed optimism over the possibility of a vaccine for the coronavirus.

The stock market in general moved higher on Feb. 5 as the Nasdaq Composite (INDEXNASDAQ: IXIC) was also up, although less than the S&P 500 index (INDEXSP: .INX) and the Dow. The Nasdaq managed a new record during the regular trading day, following the previous record set the day before.

The post S&P 500 (INDEXSP: .INX) in the red for a third straight day appeared first on ValueWalk.

Read More

Continue Reading

International

Red Candle In The Wind

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by…

Published

on

Red Candle In The Wind

By Benjamin PIcton of Rabobank

February non-farm payrolls superficially exceeded market expectations on Friday by printing at 275,000 against a consensus call of 200,000. We say superficially, because the downward revisions to prior months totalled 167,000 for December and January, taking the total change in employed persons well below the implied forecast, and helping the unemployment rate to pop two-ticks to 3.9%. The U6 underemployment rate also rose from 7.2% to 7.3%, while average hourly earnings growth fell to 0.2% m-o-m and average weekly hours worked languished at 34.3, equalling pre-pandemic lows.

Undeterred by the devil in the detail, the algos sprang into action once exchanges opened. Market darling NVIDIA hit a new intraday high of $974 before (presumably) the humans took over and sold the stock down more than 10% to close at $875.28. If our suspicions are correct that it was the AIs buying before the humans started selling (no doubt triggering trailing stops on the way down), the irony is not lost on us.

The 1-day chart for NVIDIA now makes for interesting viewing, because the red candle posted on Friday presents quite a strong bearish engulfing signal. Volume traded on the day was almost double the 15-day simple moving average, and similar price action is observable on the 1-day charts for both Intel and AMD. Regular readers will be aware that we have expressed incredulity in the past about the durability the AI thematic melt-up, so it will be interesting to see whether Friday’s sell off is just a profit-taking blip, or a genuine trend reversal.

AI equities aside, this week ought to be important for markets because the BTFP program expires today. That means that the Fed will no longer be loaning cash to the banking system in exchange for collateral pledged at-par. The KBW Regional Banking index has so far taken this in its stride and is trading 30% above the lows established during the mini banking crisis of this time last year, but the Fed’s liquidity facility was effectively an exercise in can-kicking that makes regional banks a sector of the market worth paying attention to in the weeks ahead. Even here in Sydney, regulators are warning of external risks posed to the banking sector from scheduled refinancing of commercial real estate loans following sharp falls in valuations.

Markets are sending signals in other sectors, too. Gold closed at a new record-high of $2178/oz on Friday after trading above $2200/oz briefly. Gold has been going ballistic since the Friday before last, posting gains even on days where 2-year Treasury yields have risen. Gold bugs are buying as real yields fall from the October highs and inflation breakevens creep higher. This is particularly interesting as gold ETFs have been recording net outflows; suggesting that price gains aren’t being driven by a retail pile-in. Are gold buyers now betting on a stagflationary outcome where the Fed cuts without inflation being anchored at the 2% target? The price action around the US CPI release tomorrow ought to be illuminating.

Leaving the day-to-day movements to one side, we are also seeing further signs of structural change at the macro level. The UK budget last week included a provision for the creation of a British ISA. That is, an Individual Savings Account that provides tax breaks to savers who invest their money in the stock of British companies. This follows moves last year to encourage pension funds to head up the risk curve by allocating 5% of their capital to unlisted investments.

As a Hail Mary option for a government cruising toward an electoral drubbing it’s a curious choice, but it’s worth highlighting as cash-strapped governments increasingly see private savings pools as a funding solution for their spending priorities.

Of course, the UK is not alone in making creeping moves towards financial repression. In contrast to announcements today of increased trade liberalisation, Australian Treasurer Jim Chalmers has in the recent past flagged his interest in tapping private pension savings to fund state spending priorities, including defence, public housing and renewable energy projects. Both the UK and Australia appear intent on finding ways to open up the lungs of their economies, but government wants more say in directing private capital flows for state goals.

So, how far is the blurring of the lines between free markets and state planning likely to go? Given the immense and varied budgetary (and security) pressures that governments are facing, could we see a re-up of WWII-era Victory bonds, where private investors are encouraged to do their patriotic duty by directly financing government at negative real rates?

That would really light a fire under the gold market.

Tyler Durden Mon, 03/11/2024 - 19:00

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

Trending